We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+10.92%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$126B
AUM Growth
+$7.85B
(+6.6%)
Cap. Flow
-$3.09B
Cap. Flow
% of AUM
-2.45%
Top 10 Holdings %
Top 10 Hldgs %
35.91%
Holding
339
New
8
Increased
67
Reduced
188
Closed
5
Top Buys
| 1 |
Albemarle
ALB
|
+$171M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$157M |
| 3 |
New Fortress Energy
NFE
|
+$100M |
| 4 |
Alibaba
BABA
|
+$70.3M |
| 5 |
Boeing
BA
|
+$64M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$1.33B |
| 2 |
Eli Lilly
LLY
|
+$504M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$432M |
| 4 |
Novartis
NVS
|
+$163M |
| 5 |
JPMorgan Chase
JPM
|
+$125M |
Sector Composition
| 1 | Technology | 31.7% |
| 2 | Healthcare | 30.82% |
| 3 | Industrials | 11.15% |
| 4 | Consumer Discretionary | 9.2% |
| 5 | Financials | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Globus Medical
GMED
$10.3B
| $2.78M | ﹤0.01% |
52,125
-300
| -0.6% | -$14.6K |
|
302
Marqeta
MQ
$1.7B
| $2.62M | ﹤0.01% |
93,800
+18,750
| +25% | +$449K |
|
303
Freshworks
FRSH
$2.89B
| $2.55M | ﹤0.01% |
108,500
-15,400
| -12% | -$305K |
|
304
Ingevity
NGVT
$2.54B
| $2.46M | ﹤0.01% |
52,000
| – | – |
|
305
Cboe Global Markets
CBOE
$28.8B
| $2.32M | ﹤0.01% |
13,000
-2,100
| -14% | -$360K |
|
306
Amylyx Pharmaceuticals
AMLX
$2.02B
| $2.31M | ﹤0.01% |
156,900
-148,000
| -49% | -$2.27M |
|
307
Snap
SNAP
$7.87B
| $2.26M | ﹤0.01% |
133,250
| – | – |
|
308
Veralto
VLTO
$22.6B
| $2.23M | ﹤0.01% |
+27,111
| New | +$2.02M |
|
309
Five Below
FIVE
$10.7B
| $1.94M | ﹤0.01% |
9,100
-100
| -1% | -$18.4K |
|
310
Tapestry
TPR
$27.3B
| $1.93M | ﹤0.01% |
+52,500
| New | +$1.62M |
|
311
Ambarella
AMBA
$3.2B
| $1.92M | ﹤0.01% |
31,300
-1,800
| -5% | -$98.3K |
|
|
LICY
312
DELISTED
Li-Cycle Holdings Corp.
LICY
| $1.92M | ﹤0.01% |
410,025
+11,350
| +3% | +$129K |
|
313
10x Genomics
TXG
$5.81B
| $1.76M | ﹤0.01% |
31,400
+1,300
| +4% | +$56.6K |
|
314
Arista Networks
ANET
$230B
| $1.68M | ﹤0.01% |
28,600
| – | – |
|
|
JAMF
315
DELISTED
Jamf
JAMF
| $1.64M | ﹤0.01% |
90,900
| – | – |
|
|
SAGE
316
DELISTED
Sage Therapeutics
SAGE
| $1.62M | ﹤0.01% |
74,950
-14,900
| -17% | -$295K |
|
317
Greif Class B
GEF.B
$3.29B
| $1.58M | ﹤0.01% |
24,000
| – | – |
|
|
SNCY
318
DELISTED
Sun Country Airlines
SNCY
| $1.56M | ﹤0.01% |
99,005
-900
| -0.9% | -$13.2K |
|
|
MURA
319
DELISTED
Mural Oncology
MURA
| $1.52M | ﹤0.01% |
+256,255
| New | +$1.03M |
|
320
NN Inc
NNBR
$264M
| $1.51M | ﹤0.01% |
377,400
-4,000
| -1% | -$9.51K |
|
321
Darden Restaurants
DRI
$22.4B
| $1.31M | ﹤0.01% |
8,000
| – | – |
|
|
SAFE
322
Safehold
SAFE
$1.18B
| $1.25M | ﹤0.01% |
53,600
| – | – |
|
323
Bloom Energy
BE
$69.2B
| $734K | ﹤0.01% |
49,600
| – | – |
|
|
ZIMV
324
DELISTED
ZimVie
ZIMV
| $719K | ﹤0.01% |
40,510
-149,500
| -79% | -$1.51M |
|
325
Adaptive Biotechnologies
ADPT
$3.43B
| $716K | ﹤0.01% |
146,190
| – | – |
|
Similar funds
